Healthcare Distribution and Pharmaceutical Services
Strategic Profile
Cardinal Health expects Specialty revenues to exceed $50 billion in fiscal 2026, representing a 16% three-year compound annual growth rate. The completion of the Solaris Health acquisition, major digital platform wins in biopharma, and continued logistics innovation each contributed to market momentum and expansion opportunities. The company's competitive advantage lies in its integrated platform combining core distribution with high-margin specialty and managed services organizations (MSOs).
Cyborg Score Rationale
Cardinal Health lifted full-year fiscal 2026 non-GAAP EPS guidance to $10.15 to $10.35, representing 23% to 26% growth. Q2 revenue grew 19% year-over-year to $65.6B, with non-GAAP EPS up 36% and broad-based segment strength, especially in pharmaceuticals. The company demonstrates exceptional execution with consistent guidance raises and strong momentum across all segments.
Top Insights
The Pharmaceutical and Specialty Solutions segment, Cardinal's largest, generated $60.7 billion in revenue, up 19% on brand and specialty pharmaceutical demand.
Cardinal Health's Specialty Alliance completed the acquisition of Solaris Health, the country's leading Urology MSO with over 750 providers, on November 3rd.
BioPharma Solutions' expected greater than 30% revenue growth in fiscal 2026 with Sonexus serving over 1 million patients.
Management executed $750M in share repurchases year-to-date, underscoring commitment to capital return and reducing outstanding shares by 2.5%.
Named Competitors
Cencora — Large-cap pharmaceutical and medical distributor
McKesson — Healthcare distributor and technology solutions provider
Henry Schein — Medical, dental, and animal health distributor
Recent Developments
(February 2026) Raised fiscal 2026 non-GAAP EPS guidance to $10.15-$10.35, Q2 revenue of $65.6B up 19% year-over-year
(November 2025) Completed acquisition of Solaris Health, the leading Urology MSO with over 750 providers
(October 2025) Announced ContinuCare Pathway program for diabetes supply management across 11,000 pharmacies with Publix partnership
Open the full interactive Cardinal Health, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.